“Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Phase III Clinical Trials Pooled Analysis Results”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s102. Accessed April 19, 2026. https://skin.dermsquared.com/skin/article/view/177.